A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/436 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2629714
The invention features methods for treatment of a patient in need thereof with the administration of mammalian target of rapamycin (mTOR) inhibitors such as sirolimus, temsirolimus, everolimus or rapamycin analogs including AP23573, especially to a cancer patient for 4 or 5 consecutive days per week. The mTOR inhibitor therapy can be used for a wide range of cancers including prostrate, pancreas, ovary, lung, breast, bladder, colon, brain, head and neck, endometrium, leukemia, lymphoma and sarcoma.
La présente invention concerne des procédés destinés à traiter un patient avec un inhibiteur de mTOR tel que l'AP23573, le sirolimus, le temsirolimus, l'everolimus, etc.
Ariad Gene Therapeutics Inc.
Ariad Pharmaceuticals Inc.
Borden Ladner Gervais Llp
LandOfFree
Administration of an mtor inhibitor to treat patients with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Administration of an mtor inhibitor to treat patients with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Administration of an mtor inhibitor to treat patients with... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1981204